Affiliate disclosure: some links on this page are affiliate links and may earn us a commission at no extra cost to you — it never affects our rankings or reviews.

Guide · Semaglutide · United States

Compounded semaglutide in the US: what it is, its legal status and who sells it

Compounded semaglutide is semaglutide prepared by a compounding pharmacy for an individual prescription, not the brand-name Wegovy and Ozempic made by Novo Nordisk. It is not FDA approved.[1] US online programs price it from $39 to $299 a month on a month to month plan (median $94 a month), in our read of November 19, 2026, usually for the lowest dose.

Since the semaglutide shortage ended, pharmacies may no longer routinely compound copies of Wegovy; a prescriber can still order it for an individual patient with a documented clinical need, and the FDA has said it intends to restrict mass-marketed compounded GLP-1 products. This page sets out the legal position with dated sources, the FDA's safety concerns, who sells it online and how to check a seller. It is not legal or medical advice.

Edited by Gabriel BrocklesbyFounder & EditorFact-checkedLast updated

During a shortage, the FDA lets pharmacies compound copies of an approved drug. Once a shortage ends, that permission winds down. Key dates for semaglutide:

  • Feb 21, 2025: The FDA declared the shortage of semaglutide injection products (Ozempic and Wegovy) resolved.[2],[3]
  • Apr 22, 2025: The end of the period in which the FDA said it would not act against state-licensed 503A pharmacies compounding semaglutide as they had during the shortage.[3],[4]
  • May 22, 2025: The same date for 503B outsourcing facilities. Both dates applied unless a court ruled sooner in the lawsuit brought against the FDA's decision.[3],[4]
  • Feb 6, 2026: The FDA said it intends to restrict the GLP-1 active ingredients used in mass-marketed compounded drugs that are not FDA approved, and that sellers may not claim such products are generic versions of, equivalent to or the same as FDA-approved drugs. It said it could seek seizures or injunctions.[7]
  • March 2026: The FDA sent warning letters to 30 telehealth companies over misleading marketing of compounded GLP-1 products.[8]
  • May 1, 2026: The FDA published a notice proposing not to include semaglutide, tirzepatide or liraglutide on the 503B bulks list, the list of substances outsourcing facilities may compound from bulk. A final determination is still pending.[9],[8]

What the rules allow now

  • A 503A pharmacy (a state-licensed pharmacy compounding for an individual patient's prescription) may not regularly compound what the law calls "essentially a copy" of a commercially available drug: the same active ingredient, strength, dosage form and route as the approved product. That applies even when other ingredients are added.[5],[6]
  • A prescriber can still order a compounded version for an individual patient when they document a clinically significant difference that the patient needs. Cost savings alone is not enough, and adding an ingredient such as vitamin B12 does not on its own make a product different.[5],[6]
  • 503B outsourcing facilities generally may not lawfully compound these drugs, the Kentucky Board of Pharmacy told pharmacies in November 2025.[6]
  • Sellers may not market a compounded product as a generic version of, equivalent to or the same as an FDA-approved drug.[7]
  • Salt forms, such as semaglutide sodium and semaglutide acetate, are different active ingredients from the semaglutide in approved products. The FDA says it is not aware of any lawful basis for their use in compounding.[1]

Is compounded semaglutide safe? What the FDA says

  • Compounded drugs are not FDA approved, and the FDA does not review them for safety, effectiveness or quality before they are marketed.[1]
  • The FDA says compounded drugs should only be used in patients whose medical needs cannot be met by an FDA-approved drug.[1]
  • As of May 31, 2026, the FDA had received 990 reports of adverse events associated with compounded semaglutide, and it notes that adverse events are likely underreported.[1]
  • The FDA has received reports of adverse events, some needing hospital care, that may be related to dosing errors, including patients measuring the wrong amount and professionals miscalculating doses.[1]
  • The FDA warns of fraudulent compounded products whose labels carry false information, some listed under pharmacies that do not exist, and it has warned companies selling products falsely labeled "for research purposes" or "not for human consumption".[1]
  • The FDA asks patients and clinicians to report side effects or quality problems through its MedWatch program.[1]

We give no dosing, storage or injection advice. Your prescriber and pharmacist should explain how to use any medicine they supply.

Who sells compounded semaglutide online

20 US online programs print a compounded semaglutide price on their own page. Each figure below is read daily from that page, with the day we read it; the latest read was November 19, 2026. A plan price is the per month figure of a prepaid plan, billed up front.

#ProviderPriceWhat the price isCurrent offerCheckedLink
1
welludr logo
welludrsemaglutide
$39/moStarting at, advertised sale price, per monthPage wording: BLACK FRIDAY SALE DISCOUNT APPLIED $39 /mo Semaglutide $69 /mo TirzepatideNew Customer Offer: $150 off for LifeOffer end date not statedSee pricing
2
Embody logo
Embodysemaglutide
$49/moadvertised sale price, per monthPage wording: PRE-BLACK FRIDAY SALE DISCOUNT APPLIED! $49 Semaglutide / $99 TirzepatidePRE-BLACK FRIDAY SALE DISCOUNT APPLIED!Standard price Was $299Sale end recorded: Nov 24See pricing
3
REBL logo
REBLsemaglutide
$55/moFrom, ongoing monthly pricePage wording: Treatments from $55/moNone recorded
4
Collective logo
Collectivesemaglutide
$59/moongoing monthly price; plus a required $199 annual membershipPage wording: Compounded Semaglutide $59/mo. Same price, any dose.None recordedSee pricing
5
SnagRx logo
SnagRxsemaglutide
$59/moadvertised sale price, per monthPage wording: PRE-BLACK FRIDAY SALE DISCOUNT APPLIED! Semaglutide for $59 / Tirzepatide for $109PRE-BLACK FRIDAY SALE DISCOUNT APPLIED!Standard price Was $299Sale end recorded: Nov 24See pricing
6
Arbor logo
Arborsemaglutide
$89/moFrom, ongoing monthly pricePage wording: Semaglutide From $89/moNone recordedSee pricing
7
Yucca Health logo
Yucca Healthsemaglutide
$89/moFrom, ongoing monthly pricePage wording: Monthly Plan Billed monthly · no commitment $89 /mo was $146/moNone recordedPaused: not currently accepting new patients through our links. See alternatives
8
bmiMD logo
bmiMDsemaglutide
$99/moStarting as low as, ongoing monthly pricePage wording: Compounded Semaglutide Starting as low as $99/moNone recordedSee pricing
9
Eden Health logo
Eden Healthsemaglutide
$99/moongoing monthly pricePage wording: Semaglutide $99 /moNone recordedSee pricing
10
GobyMeds logo
GobyMedssemaglutide
$99/moStarting at, per month on a prepaid plan: 3-month starter bundle, $299 billedPage wording: Starting at $99/m Compounded Semaglutide 3-Month Starter Bundle ... Total $299None recordedSee pricing
11
Trimi logo
Trimisemaglutide
$99/moper month on a prepaid plan: 12-month plan, $1,188 billedPage wording: 12 months Lowest rate $99/mo $1,188 billed upfrontNone recordedPaused: not currently accepting new patients through our links. See alternatives
12
Strut Health logo
Strut Healthsemaglutide
$129/moongoing monthly pricePage wording: SEMAGLUTIDE INJECTABLE $129 Monthly vialNone recordedSee pricing
13
TMates logo
TMatessemaglutide
$158/moper month on a prepaid plan: 12 months, $1,900 billedPage wording: 12 Months$158/mo Save 37% $1900None recordedPaused: not currently accepting new patients through our links. See alternatives
14$159.33/moper month on a prepaid plan: 3-month bundle, $478 billedPage wording: $159.33/mo on 3-month bundleFirst month $179 (standard $279)Offer end date not statedSee pricing
15
GobyMeds logo
GobyMedssemaglutide
$169/moongoing monthly pricePage wording: Compounded Semaglutide (GLP-1) Single Month $169+ One month at any dosage.None recordedSee pricing
16
MEDGm logo
MEDGmsemaglutide
$169/moper month on a prepaid plan: 12-Month Supply, $2,028 billedPage wording: 12-Month Supply Billed every 12 months $2,028 $169/moNone recordedSee pricing
17
Sprout Health logo
Sprout Healthsemaglutide
$169/moStarting at, ongoing monthly pricePage wording: Compounded semaglutide Starting at $169/moNone recordedSee pricing
18
Shed logo
Shedsemaglutide
$175/moStarting at, ongoing monthly pricePage wording: BLACK FRIDAY PRICE LOCKED FOREVER Compounded Semaglutide $175 /mo was $199 Billed as $350 every 2 monthsNone recordedSee pricing
19
Trimi logo
Trimisemaglutide
$175/moongoing monthly pricePage wording: Monthly $175/mo $175 billed every monthNone recordedPaused: not currently accepting new patients through our links. See alternatives
20
Strut Health logo
Strut Healthsemaglutide
$199price for a 30-day supplyPage wording: SEMAGLUTIDE ORAL $199 30-day supplyNone recordedSee pricing
21
Luvo Health logo
Luvo Healthsemaglutide
$209price per 4 weeks, billed every 4 weeksPage wording: 4 weeks of injections, delivered every 4 weeks. $209 from your second delivery.None recordedSee pricing
22
TMates logo
TMatessemaglutide
$249/moongoing monthly pricePage wording: Choose Your Plan 1 Month $249None recordedPaused: not currently accepting new patients through our links. See alternatives
23
Found logo
Foundsemaglutide
$289/moongoing monthly pricePage wording: Compounded semaglutide 1 month $199/mo $289/moNone recordedSee pricing
24
MEDGm logo
MEDGmsemaglutide
$299/moongoing monthly pricePage wording: Month to Month $179 for first month then $299/mo.None recordedSee pricing
25
Wellorithm logo
Wellorithmsemaglutide
$299/moongoing monthly pricePage wording: Compounded semaglutide ongoing (every month) $299First month $179Offer end date not statedSee pricing
26
MEDGm logo
MEDGmsemaglutide
$369/moongoing monthly pricePage wording: Month to Month $249 for first month then $369/mo.None recordedSee pricing

Compounded medicines are not FDA-approved.

Regulatory note: After the FDA declared the semaglutide shortage resolved in February 2025, pharmacies could no longer routinely compound copies of that licensed product. On May 1, 2026 the FDA published a notice proposing not to include semaglutide, tirzepatide or liraglutide on the 503B Bulks List; a final determination is still pending. The availability and pricing described here may not reflect what a provider can currently supply, so confirm the current offering and cost directly with any provider before relying on it.Last reviewed: July 2026

Source: FDA: Declaratory Order: Resolution of Shortages of Semaglutide Injection Products (Ozempic and Wegovy) · United States · Decision February 21, 2025

Source: FDA: Federal Register notice — List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B · United States · Published May 1, 2026

Compounded semaglutide vs Wegovy

The two are different products, so the price gap is not a discount on the same medicine. These are cash prices from our archive, each with the day we read it.

OptionFDA approvedLowest cash price we holdChecked
Wegovy pillYes$149 a month at Hims; membership $149/mo month to month, $39 the first month, billed separatelyNov 19, 2026
Wegovy penYes$199 a month at Hims; membership $149/mo month to month, $39 the first month, billed separatelyNov 19, 2026
Wegovy list priceYes$1,349.02, the published list price insurers are billed againstNov 19, 2026
Compounded semaglutide, lowestNo$39/mo month to month at welludr, an advertised sale price; usually the lowest doseNov 19, 2026
Compounded semaglutide, medianNo$94 a month, the median month to month price across 12 programsNov 19, 2026

Wegovy is reviewed by the FDA for safety, effectiveness and quality; compounded versions are not.[1]

How to check a compounded semaglutide seller

  • A named, state-licensed pharmacy fills the prescription, and the program tells you which one. The FDA's BeSafeRx campaign advises buying prescription medicines only from state-licensed online pharmacies; you can check a license with the state board of pharmacy.[10]
  • The program or its pharmacy holds LegitScript certification, which you can look up by website address.[11]
  • A licensed prescriber reviews your health history before anything is prescribed. Compounding by a 503A pharmacy rests on a prescription for an individual patient.[5],[6]
  • The product is never sold "for research purposes" or "not for human consumption". The FDA has warned companies selling GLP-1 products under those labels.[1]
  • The seller does not call its product a generic, an equivalent or the same as the brand-name medicine, which the FDA says it may not claim.[7]

For every compounded semaglutide price ranked lowest first, see cheapest semaglutide online.

For brand-name cash prices by seller, see Wegovy cost without insurance.

For plans, support and refund terms side by side, see semaglutide providers compared.

The other compounded GLP-1 sold online has its own guide: compounded tirzepatide, with its legal status, the FDA's concerns and who sells it.

For life on treatment, our GLP-1 diet plan covers what to eat, what to limit and how much protein, and our guide to GLP-1 microdosing lists which online programs offer it and what it costs.

Frequently asked questions

What is compounded semaglutide?

Compounded semaglutide is semaglutide prepared by a compounding pharmacy for an individual prescription, rather than manufactured by Novo Nordisk as Wegovy or Ozempic. It is sold by US telehealth programs after an online review by a licensed prescriber. It is not FDA approved, and the FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed.

Is compounded semaglutide the same as Ozempic or Wegovy?

No. Wegovy and Ozempic are FDA-approved medicines made by Novo Nordisk. Compounded semaglutide is made by a compounding pharmacy and is not FDA approved. In February 2026 the FDA said sellers may not claim a compounded product is a generic version of, equivalent to or the same as an FDA-approved drug.

Is compounded semaglutide safe?

The FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed, and says they should only be used when a patient's medical needs cannot be met by an approved drug. As of May 31, 2026 it had received 990 adverse event reports for compounded semaglutide, some linked to dosing errors, and it warns about fraudulent products and salt forms such as semaglutide sodium. Ask your prescriber about the risks for you.

Does compounded semaglutide work?

The FDA has not reviewed compounded semaglutide for effectiveness. The clinical trial results published for Wegovy apply to the FDA-approved product, and no FDA review shows that a compounded version performs the same way. A licensed prescriber can explain what is known for your situation.

Is compounded semaglutide still available, or will it be banned?

US online programs still list it: the table on this page shows 20 with a price we read on November 19, 2026. Since the shortage ended in February 2025, a 503A pharmacy may no longer routinely compound copies of the approved drug, though a prescriber can still order it for an individual patient with a documented clinical need. In 2026 the FDA said it intends to restrict GLP-1 ingredients in mass-marketed compounded products and proposed keeping semaglutide off the 503B bulks list; a final decision is still pending.

How much does compounded semaglutide cost?

In our latest read, month to month prices for compounded semaglutide from US online programs run from $39 to $299 a month, with a median of $94 a month (checked November 19, 2026). Most are starting prices for the lowest dose, and some are sale prices. Our cheapest semaglutide online guide ranks every price.

How do I get compounded semaglutide?

Through a licensed prescriber, usually at a US telehealth program, who reviews your health history and decides whether a compounded medicine is right for you. Check that a named, state-licensed pharmacy fills it, that the program holds LegitScript certification, and never buy from a seller labeling it "for research purposes".

Sources

  1. FDA, "FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss" (content current as of Oct 1, 2026). Read Nov 10, 2026.
  2. FDA, Declaratory Order: Resolution of Shortages of Semaglutide Injection Products (Ozempic and Wegovy), Feb 21, 2025. Read Nov 10, 2026.
  3. Drug Topics, "FDA Declares Shortage of Ozempic, Wegovy Resolved", Feb 21, 2025. Read Nov 10, 2026.
  4. TechTarget, "FDA winds down GLP-1 compounding policies", Apr 1, 2025. Read Nov 10, 2026.
  5. Best Lawyers (Keith Lefkowitz), "The GLP-1 Shortage Has Ended. Can You Still Legally Compound?", Aug 21, 2025. Read Nov 10, 2026.
  6. Kentucky Board of Pharmacy, compounding compliance alert on GLP-1 and GIP/GLP-1 drugs, Nov 14, 2025. Read Nov 10, 2026.
  7. Pharmacy Times, "FDA Moves to Restrict Mass-Marketed Compounded GLP-1 Products", Feb 12, 2026. Read Nov 10, 2026.
  8. Becker's Hospital Review, "FDA warns on compounded GLP-1s amid 1,700 safety reports", Sep 8, 2026. Read Nov 10, 2026.
  9. Federal Register, List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B (proposed), May 1, 2026. Read Nov 10, 2026.
  10. FDA, "About BeSafeRx" (content current as of Feb 18, 2025). Read Nov 10, 2026.
  11. LegitScript, Website Certification Status lookup. Read Nov 10, 2026.